Company intelligence / Profile preview

Golden Developing Solutions

Fort Lauderdale, Florida, United States

Ownership: Private
Employees: ~53
Development stage: Other

Overview

Golden Developing Solutions operated as an online health and wellness holding company, running an Internet retail business for CBD, hemp oil, vitamins, supplements and related health products, and providing specialty medicine with rapid delivery and telemedicine services through subsidiaries such as Renown RX. It experienced prolonged financial distress and regulatory headwinds, ultimately filing for Chapter 11 bankruptcy on June 22, 2023, which was converted to Chapter 7 liquidation on August 7, 2024. There is no evidence of drug R&D or clinical trial programs.

Therapeutic areas: Other
Modalities: Small molecule
Industry: Food & Nutrition

Partnerships

Growth strategy focused on acquisitions of smaller health/wellness and pharmacy/telehealth businesses rather than R&D alliances.

Beyond the preview

Go deeper on Golden Developing Solutions.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Golden Developing Solutions.

Explore the full profile